Vice Health and Wellness Inc.
VICE
CNSX
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 861.76% | 4,523.81% | 357.37% | 2.12% | -88.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 861.76% | 4,523.81% | 357.37% | 2.12% | -88.07% |
| Cost of Revenue | -9.28% | -11.22% | -25.84% | -57.29% | -12.92% |
| Gross Profit | 82.51% | 87.71% | 86.16% | 82.07% | -85.04% |
| SG&A Expenses | -48.57% | -26.90% | -17.39% | -12.02% | -4.39% |
| Depreciation & Amortization | -51.00% | -27.17% | -26.77% | -25.79% | -41.08% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.43% | -25.70% | -18.11% | -16.01% | -6.03% |
| Operating Income | 51.14% | 31.50% | 21.77% | 16.46% | 1.78% |
| Income Before Tax | 58.69% | 37.35% | 20.74% | 15.12% | 19.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.69% | 37.35% | 20.74% | 15.12% | 19.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.69% | 37.35% | 20.74% | 15.12% | 33.27% |
| EBIT | 51.14% | 31.50% | 21.77% | 16.46% | 1.78% |
| EBITDA | 66.98% | 47.19% | 35.10% | 30.53% | 2.48% |
| EPS Basic | 70.90% | 53.17% | 52.23% | 53.36% | 68.62% |
| Normalized Basic EPS | 66.23% | 48.97% | 53.27% | 53.19% | 42.74% |
| EPS Diluted | 70.90% | 53.17% | 52.23% | 55.72% | 69.63% |
| Normalized Diluted EPS | 66.23% | 48.97% | 53.27% | 53.19% | 42.74% |
| Average Basic Shares Outstanding | 92.95% | 34.64% | 50.07% | 69.59% | 87.45% |
| Average Diluted Shares Outstanding | 92.95% | 34.64% | 50.07% | 69.59% | 87.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
